Navigation Links
Dynatronics Announces Fiscal Second Quarter Results

SALT LAKE CITY, Feb. 14, 2011 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced results for its fiscal second quarter ended December 31, 2010.

Sales for the quarter ended December 31, 2010, were $8,199,347, compared to $8,501,437 for the quarter ended December 31, 2009. Sales for the six months ended December 31, 2010, were $16,118,635, compared to $16,783,900 for the similar period of the prior year.

Net income for the quarter ended December 31, 2010, was $67,839 ($.01 per common share), compared to $188,299 ($.01 per common share) for the same quarter in the prior fiscal year. Net income for the six months ended December 31, 2010, was $84,851 ($.01 per common share), compared to $256,923 ($.02 per common share) for the same period in the prior fiscal year.

"Higher R&D expenses of $149,637 for the quarter and $283,465 for the six month period were a primary reason for reporting lower profits this year over last year.  In addition, slower demand for capital equipment due to lingering recessionary pressures also contributed," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "However, our R&D pipeline is as strong as ever with several new products under development. New products have always been the lifeblood of our business."

The company recently announced the signing of major contracts with two group purchasing organizations ("GPOs"): Premier and Amerinet. Together, these GPOs represent tens of thousands of clinics and hospitals around the nation, spending an estimated $50 million on physical medicine products annually.

"We believe these landmark agreements will be a game-changer for Dynatronics," said Larry K. Beardall, executive vice-president of sales and marketing. "Obtaining contracts with GPOs is something we have been working on for nearly three years. While it will take time to convert the vast number of clinics to our brand of products, we are already receiving requests for product quotes from GPO customers."

"As we begin to solicit sales orders under these GPO arrangements, we are gearing up our production capacity for a new level of operations," added Cullimore. "With over 12,000 products now available through our catalog and e-commerce website, we are in a good position to supply this high-volume segment of the physical medicine market."

Dynatronics has scheduled a conference call for investors on Monday, February 14, 2011, at 1:30 p.m. ET. Those wishing to participate should call (800) 926-7431 and use access code: 5687000.

Following is a summary of the financial results as of December 31, 2010, and June 30, 2010, and for the three and six month periods then ended:   Summary Selected Financial DataStatement of Income Highlights (Unaudited)Three Months EndedSix Months EndedDecember 31,December 31,2010200920102009Net sales




$16,783,900Cost of sales




10,277,181Gross profit




6,506,719SG&A expenses




5,411,726R&D expenses




422,850Other expenses, net




220,167Net income before income taxes




451,976Income tax provision




(195,053)Net income




$256,923Diluted income per common share




$0.02Balance Sheet HighlightsDecember 31,June 30,20102010(Unaudited)Cash


$383,756Accounts receivable




5,766,800Total current assets


10,609,813Total assets


$15,090,329Accounts payable


$1,404,022Accrued expenses


462,641Line of credit


2,768,492Total current liabilities


5,686,280Total liabilities


8,291,052Total liabilities and equity


$15,090,329Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future new product line introductions and growth from GPO contracts. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2010.

SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics to Release Fiscal Second Quarter Results Monday, February 14, 2011; Conference Call Set for 1:30 p.m. ET
2. Dynatronics Named Contract Supplier to Amerinets 50,000 Members
3. Dynatronics Named Contract Supplier to Premier, Inc.
4. NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance
5. Dynatronics Announces Fiscal First Quarter Results
6. Dynatronics to Release Fiscal First Quarter Results Thursday, November 11, 2010; Conference Call Set for 2:15 p.m. ET
7. Dynatronics Announces Positive Year-end Results
8. Dynatronics to Release Fourth Quarter and Year-End Results Wednesday, September 22, 2010; Conference Call Set for 1:00 p.m. ET
9. Dynatronics Launches E-Commerce Website
10. Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter
11. Dynatronics to Release Third Quarter Results Monday, May 17, 2010; Conference Call Set for 1:30 p.m. ET
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and Markets ... "Advanced Wound Care Market by Type (Dressings, Therapy ... User (In-Patient Facility, Out-Patient Facility), and Geography - Global ... --> --> The ... definition and forecast of the global advanced wound care ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... The print component of “Supporting Our Caregivers” ... New York, Minneapolis, South Florida, with a circulation of approximately 250,000 copies and ... vast social media strategy and across a network of top news sites and ...
(Date:11/27/2015)... ... 2015 , ... A simply groundbreaking television series, "Voices in America", which is ... an array of issues that are presently affecting Americans. Dedicated to providing the world ... is changing the subjects consumers focus on, one episode at a time. , ...
(Date:11/27/2015)... Rosa, CA (PRWEB) , ... November 27, 2015 , ... ... Northern California Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at ... meeting. They observed that both STEMI and Sepsis conditions present in similar ways and ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... process, participated in the 61st annual Employee Benefits Conference. The Employee Benefits Conference ... Sunday, November 8th through Wednesday, November 11th, 2015. The conference was held at ...
Breaking Medicine News(10 mins):